PTC Therapeutics Shares Outstanding 2012-2019 | PTCT

PTC Therapeutics shares outstanding from 2012 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
PTC Therapeutics Annual Shares Outstanding
(Millions of Shares)
2018 47
2017 39
2016 34
2015 34
2014 32
2013 13
2012 0
2011 0
PTC Therapeutics Quarterly Shares Outstanding
(Millions of Shares)
Q1 2019 56
Q4 2018 47
Q3 2018 48
Q2 2018 46
Q1 2018 42
Q4 2017 39
Q3 2017 41
Q2 2017 40
Q1 2017 34
Q4 2016 34
Q3 2016 34
Q2 2016 34
Q1 2016 34
Q4 2015 34
Q3 2015 34
Q2 2015 34
Q1 2015 33
Q4 2014 32
Q3 2014 29
Q2 2014 29
Q1 2014 24
Q4 2013 13
Q3 2013 24
Q2 2013 3
Q1 2013 0
Q4 2012 0
Q3 2012 0
Q2 2012 0
Q1 2012 0
Q4 2011 0
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $2.497B $0.265B
PTC Therapeutics, Inc. is a biopharmaceutical company. It is focused on the discovery and development of orally administered, small-molecule drugs for genetic disorders, oncology and infectious disease. PTC Therapeutics, Inc. is based in South Plainfield, United States.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $54.270B 34.67
Takeda Pharmaceutical (TAK) Japan $26.904B 7.90
Grifols (GRFS) Spain $13.545B 17.13
Sage Therapeutics (SAGE) United States $9.329B 0.00
Ionis Pharmaceuticals (IONS) United States $9.107B 19.91
Neurocrine Biosciences (NBIX) United States $7.829B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.485B 10.26
Catalent (CTLT) United States $7.356B 29.52
Nektar Therapeutics (NKTR) United States $6.130B 9.99
Tilray (TLRY) Canada $3.991B 0.00
FibroGen (FGEN) United States $3.795B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.537B 12.41
United Therapeutics (UTHR) United States $3.444B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.644B 398.43
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.091B 7.53
Xencor (XNCR) United States $1.946B 53.14
Portola Pharmaceuticals (PTLA) United States $1.915B 0.00
Tricida (TCDA) United States $1.836B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.808B 87.54
Enanta Pharmaceuticals (ENTA) United States $1.789B 24.45
Ironwood Pharmaceuticals (IRWD) United States $1.778B 0.00
USANA Health Sciences (USNA) United States $1.738B 15.10
Zogenix (ZGNX) United States $1.689B 0.00
Madrigal Pharmaceuticals (MDGL) United States $1.589B 0.00
Aerie Pharmaceuticals (AERI) United States $1.554B 0.00
Heron Therapeutics (HRTX) United States $1.444B 0.00
Esperion Therapeutics (ESPR) United States $1.373B 0.00
Turning Point Therapeutics (TPTX) United States $1.361B 0.00
Corcept Therapeutics (CORT) United States $1.206B 17.21
Radius Health (RDUS) United States $1.096B 0.00
ArQule (ARQL) United States $1.023B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.949B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.932B 0.00
Endo (ENDP) Ireland $0.896B 1.44
Odonate Therapeutics (ODT) United States $0.719B 0.00
Aptorum Group (APM) China $0.694B 0.00
CannTrust Holdings (CTST) Canada $0.673B 0.00
Organogenesis Holdings (ORGO) United States $0.671B 0.00
TherapeuticsMD (TXMD) United States $0.625B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.584B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.561B 0.00
Akebia Therapeutics (AKBA) United States $0.539B 0.00
Dermira (DERM) United States $0.537B 0.00
Translate Bio (TBIO) United States $0.519B 0.00
ChemoCentryx (CCXI) United States $0.506B 0.00
GlycoMimetics (GLYC) United States $0.503B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.452B 0.00
Flexion Therapeutics (FLXN) United States $0.448B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.433B 21.85
Siga Technologies (SIGA) United States $0.432B 1.02
BioCryst Pharmaceuticals (BCRX) United States $0.397B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.391B 0.00
TCR2 Therapeutics (TCRR) United States $0.389B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.386B 0.00
Collegium Pharmaceutical (COLL) United States $0.379B 0.00
Karyopharm Therapeutics (KPTI) United States $0.360B 0.00
KalVista Pharmaceuticals (KALV) United States $0.352B 0.00
Rafael Holdings (RFL) United States $0.345B 0.00
Forty Seven (FTSV) United States $0.329B 0.00
ImmunoGen (IMGN) United States $0.321B 0.00
CASI Pharmaceuticals (CASI) United States $0.306B 0.00
Harpoon Therapeutics (HARP) United States $0.295B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.286B 0.00
OptiNose (OPTN) United States $0.285B 0.00
Xeris Pharmaceuticals (XERS) United States $0.284B 0.00
Molecular Templates (MTEM) United States $0.282B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.264B 0.00
Concert Pharmaceuticals (CNCE) United States $0.261B 0.00
Dova Pharmaceuticals (DOVA) United States $0.252B 0.00
Aratana Therapeutics (PETX) United States $0.239B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.233B 0.00
Recro Pharma (REPH) United States $0.214B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.214B 0.00
Lannett Co Inc (LCI) United States $0.214B 2.08
Aclaris Therapeutics (ACRS) United States $0.202B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.198B 0.00
Ocular Therapeutix (OCUL) United States $0.192B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.191B 0.00
Aldeyra Therapeutics (ALDX) United States $0.188B 0.00
Calithera Biosciences (CALA) United States $0.186B 0.00
MEI Pharma (MEIP) United States $0.185B 0.00
Bio Blast Pharma (ENLV) Israel $0.177B 0.00
Galectin Therapeutics (GALT) United States $0.176B 0.00
Opexa Therapeutics (ACER) United States $0.176B 0.00
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.175B 0.00
IMV INC (IMV) Canada $0.171B 0.00
Nature's Sunshine Products (NATR) United States $0.171B 55.44
Minerva Neurosciences (NERV) United States $0.171B 0.00
Jounce Therapeutics (JNCE) United States $0.159B 0.00
Ardelyx (ARDX) United States $0.157B 0.00
Redhill Biopharma (RDHL) Israel $0.154B 0.00
Majesco Entertainment (PTE) United States $0.147B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.145B 0.00
Neon Therapeutics (NTGN) United States $0.141B 0.00
AgeX Therapeutics (AGE) United States $0.135B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.135B 0.00
Tyme Technologies (TYME) United States $0.122B 0.00
Aquestive Therapeutics (AQST) United States $0.119B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.116B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.108B 0.00
MediWound (MDWD) Israel $0.097B 0.00
Champions Oncology (CSBR) United States $0.097B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.096B 68.89
Iterum Therapeutics (ITRM) Ireland $0.095B 0.00
Avenue Therapeutics (ATXI) United States $0.094B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.093B 0.00
Natural Alternatives (NAII) United States $0.092B 9.17
DURECT (DRRX) United States $0.092B 0.00
Cardiome Pharma (CORV) Canada $0.092B 0.00
Infinity Pharmaceuticals (INFI) United States $0.091B 0.00
Capnia (SLNO) United States $0.090B 0.00
Mast Therapeutics (SVRA) United States $0.085B 0.00
Adherex Technologies (FENC) United States $0.085B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.081B 0.00
Nivalis Therapeutics (ALPN) United States $0.081B 0.00
Otonomy (OTIC) United States $0.078B 0.00
China SXT Pharmaceuticals (SXTC) China $0.077B 0.00
Genocea Biosciences (GNCA) United States $0.072B 0.00
Novan (NOVN) United States $0.069B 0.00
SCYNEXIS (SCYX) United States $0.069B 0.00
Neos Therapeutics (NEOS) United States $0.066B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.066B 0.00
CTI BioPharma (CTIC) United States $0.056B 0.00
ElectroCore (ECOR) United States $0.054B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.052B 0.00
Zafgen (ZFGN) United States $0.052B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.051B 0.00
KemPharm (KMPH) United States $0.051B 0.00
AIT Therapeutics (AITB) Israel $0.050B 0.00
India Globalization Capital (IGC) United States $0.049B 0.00
ProNAi Therapeutics (SRRA) Canada $0.048B 0.00
Forward Pharma (FWP) Denmark $0.046B 0.00
Lipocine (LPCN) United States $0.045B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.044B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.041B 0.00
Mannatechorporated (MTEX) United States $0.041B 0.00
Bio-Path Holdings (BPTH) United States $0.040B 0.00
BioLineRx (BLRX) Israel $0.039B 0.00
ContraFect (CFRX) United States $0.039B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.038B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.037B 0.00
ProPhase Labs (PRPH) United States $0.034B 0.00
PharmAthene (ALT) United States $0.032B 0.00
IsoRay (ISR) United States $0.029B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.028B 0.00
Heat Biologics (HTBX) United States $0.026B 0.00
Regulus Therapeutics (RGLS) United States $0.024B 0.00
Citius Pharmaceuticals (CTXR) United States $0.024B 0.00
Melinta Therapeutics (MLNT) United States $0.023B 0.00
Biomerica (BMRA) United States $0.022B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.021B 0.00
Onconova Therapeutics (ONTX) United States $0.020B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.020B 1.59
Pain Therapeutics (SAVA) United States $0.020B 0.00
NanoViricides (NNVC) United States $0.019B 0.00
PRECISION THERAPEUTICS INC (POAI) United States $0.018B 0.00
Achieve Life Sciences (ACHV) United States $0.018B 0.00
Cyanotech (CYAN) United States $0.018B 0.00
HANCOCK JAFFE (HJLI) United States $0.015B 0.00
ESSA Pharma (EPIX) Canada $0.015B 0.00
Shineco (TYHT) China $0.014B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.014B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.011B 0.00
VAXART, INC (VXRT) United States $0.011B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.011B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.011B 1.78
Ohr Pharmaceuticals (OHRP) United States $0.010B 0.00
Trillium Therapeutics (TRIL) Canada $0.010B 0.00
RXi Pharmaceuticals (PHIO) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
Jaguar Animal Health (JAGX) United States $0.009B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.005B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.004B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
Can-Fite Biopharma (CANF) Israel $0.004B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00